A multicentre randomised placebo-controlled double-blind clinical trial for evaluation of the optimal dose for safety and efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed Allergoid Preparation of House Dust Mite (Dermatophagoides pteronyssinus) in patients with controlled allergic bronchial asthma + rhinitis/rhinoconjunctivitis - Phase II dose finding trial of specific immunotherapy with allergoid preparation of house dust mites
Open label phase II multicentre clinical trial to evaluate safety during shortened uptitration of an allergoid grass pollen preparation in adult patients with IgE mediated allergic rhinitis / rhinoconjunctivitis with or without controlled bronchial asthma - Allergoid-Grass pollen, shortened uptitration phase II safety study
Double-blind, placebo controlled study to investigate the dose response of an allergoid preparation of Phleum pratense in adult patients with IgE mediated allergic Rhinitis / Rhinoconjunctivitis with or without controlled bronchial Asthma - allergoid Phleum pratense, dose response
100 项与 Allergopharma Joachim Ganzer KG /IVD Business/ 相关的临床结果
0 项与 Allergopharma Joachim Ganzer KG /IVD Business/ 相关的专利（医药）
100 项与 Allergopharma Joachim Ganzer KG /IVD Business/ 相关的药物交易
100 项与 Allergopharma Joachim Ganzer KG /IVD Business/ 相关的转化医学
